IP Library Granted Patent US 10,711,289
Granted Patent B2
US 10,711,289 · App. 15/538,448 · Granted Jul 14, 2020

Method of producing and processing diamines from an engineered microorganism

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,711,289
App. No.
15/538,448
Granted
Jul 14, 2020
Kind
B2
Abstract

Provided is a method of producing and isolating a diamine produced by microbial fermentation that minimizes undesirable salt formation to provide a lower cost process.

Claims (19)

1. A process for diamine (DA) production comprising the steps of:

a) culturing a genetically engineered microorganism comprising a diamine (DA) synthesis pathway selected from the group consisting of hexamethylenediamine, cadaverine, putrescine, ethylenediamine and heptamethylenediamine with at least one exogenous nucleic acid encoding at least one enzyme of the DA synthesis pathway for producing a DA in medium under suitable conditions and for a sufficient period of time to produce DA and form one or more of DA carbonate, DA bicarbonate, and/or DA bis-bicarbonate in a cultured medium and a carbonic anhydrase in sufficient amount to (a) enhance the formation of the DA carbonate, DA bicarbonate, and/or, DA bis-bicarbonate by converting carbon dioxide to a bicarbonate and/or carbonate ions, (b) enhance the release of carbon dioxide from a solution of DA carbonate, DA bicarbonate, and/or DA bis-bicarbonate by converting a bicarbonate and/or carbonate ions to carbon dioxide, or (c) both (a) and (b);

wherein

i) carbon dioxide, carbonate, bicarbonate or carbonic acid predominantly control pH of the medium;

ii) percent dissolved inorganic carbon (DIC) in the medium is greater than or equal to 40%; and the DIC is determined by the formula:

DIC/TDCA×100

where TDCA is the Total Dissolved Counter Anions and is the sum of DIC and other anions; or

iii) at least 40% of diamine species in the medium comprises one or more of DA carbonate, DA bicarbonate, and/or DA bis-bicarbonate;

b) converting at least one or more of the DA carbonate, DA bicarbonate, and/or DA bis-bicarbonate into DA free base and carbon dioxide; and

c) isolating the DA free base.

2. The process of claim 1 , further comprising removing solids from the cultured medium to form the DA carbonate, DA bicarbonate, and/or DA bis-bicarbonate.

3. The process of claim 1 , further comprising removing water from the DA free base mixture and optional recycling water to a fermenter.

4. The process of claim 1 , further comprising extracting the DA free base with organic solvent in an extractor to form an extracted DA free base solution and aqueous raffinate, and optionally recycling the aqueous raffinate to the extractor.

5. The process of claim 1 , further comprising distilling the DA free base to form purified DA free base and organic solvent, optionally recycling the solvent to the extractor, and optionally removing undesired impurities.

6. The process of claim 1 , further comprising adding an aqueous base to remove the DA carbonate, DA bicarbonate, and/or DA bis-bicarbonate from the DA free base.

7. The process of claim 1 , wherein ≥50% to ≤99% of the diamine in the medium comprises one or more of a DA carbonate, DA bicarbonate, and/or DA bis-bicarbonate.

8. The process of claim 1 , wherein the genetically engineered microorganism further forms one or more of carbon dioxide, carbonate, bicarbonate or carbonic acid.

9. The process claim 1 , wherein one or more of carbon dioxide, carbonate, bicarbonate or carbonic acid is externally added to the medium.

10. The process claim 1 , wherein the converting at least one or more of the DA carbonate, DA bicarbonate, and/or DA bis-bicarbonate into DA free base and carbon dioxide is by heating.

Assignments (4)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2017
From: SUOMINEN, LAURI H.; GALLEHER, CONNOR J.; JAPS, MICHAEL; BURK, MARK J.; TRACEWELL, CARA
To: GENOMATICA, INC.
Reel/Frame 044080/0602 →